United States:
Health Law Diagnosed — Mintz's 2022 Health Law New Year's Resolutions (Podcast)
To print this article, all you need is to be registered or login on Mondaq.com.
The Mintz Health Law team celebrates 2022 by sharing their
health law–focused resolutions. Listen to how the team is
resolving to apply the lessons learned from the pandemic, their
industry insight, and their knowledge of state and federal
government priorities and actions to help clients and colleagues
thrive in 2022 and beyond.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
